Brief: Ironwood Pharmaceuticals Provides Update On FY 2021 Financial Guidance And Announces FY 2022 Financial Guidance
10/01/2022 12:22
Jan 10 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O :
* IRONWOOD PHARMACEUTICALS PROVIDES UPDATE ON FY 2021 FINANCIAL GUIDANCE AND
ANNOUNCES FY 2022 FINANCIAL GUIDANCE
* SEES FY REVENUE $420 MILLION TO $430 MILLION
* INITIATES BOARD AUTHORIZED SHARE REPURCHASE PROGRAM IN Q4 2021
Source text for Eikon: ID:nBw6vZcMpa
Further company coverage: IRWD.O
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation